Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.75 |
| ▸ | MEN1 | O00255 | 2/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.58 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.56 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.54 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.53 |
| ▸ | GPR84 | Q9NQS5 | 6/20 | 0.53 |
| ▸ | PPARG | P37231 | 6/20 | 0.53 |
| ▸ | PPARD | Q03181 | 6/20 | 0.53 |
| ▸ | PPARA | Q07869 | 6/20 | 0.53 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.53 |
| ▸ | TSHR | P16473 | 4/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | TLR2 | O60603 | 2/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.53 |
| ▸ | FABP4 | P15090 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Octanoic Acid SCHEMBL28832818 | 1.00 | USP2 (0.75) | USP2MEN1KMT2AKDM4EDUSP3 | |
| Stearic Acid SCHEMBL28048868 | 1.00 | USP2 (0.75) | USP2MEN1KMT2AKDM4EDUSP3 | |
| Batilol SCHEMBL28050096 | 1.00 | USP2 (0.75) | USP2MEN1KMT2AKDM4EDUSP3 | |
| Octanoic Acid SCHEMBL28725968 | 1.00 | USP2 (0.75) | USP2MEN1KMT2AKDM4EDUSP3 | |
| Stearic Acid SCHEMBL28804039 | 1.00 | USP2 (0.75) | USP2MEN1KMT2AKDM4EDUSP3 | |
| Stearic Acid SCHEMBL28436825 | 1.00 | USP2 (0.75) | USP2MEN1KMT2AKDM4EDUSP3 | |
| Palmitic Acid SCHEMBL28215317 | 1.00 | USP2 (0.75) | USP2MEN1KMT2AKDM4EDUSP3 | |
| Dodecanoate SCHEMBL28995146 | 1.00 | USP2 (0.75) | USP2MEN1KMT2AKDM4EDUSP3 | |
| Palmitic Acid SCHEMBL28358922 | 0.97 | USP2 (0.71) | USP2MEN1KMT2AKDM4EDUSP3 | |
| Decanoic Acid SCHEMBL28285361 | 0.97 | USP2 (0.71) | USP2MEN1KMT2AKDM4EDUSP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9084821-B2 | Transdermal compositions | MICRODERMIS CORPORATION (US) | 2015-07-21 | — | — | US | disclosed |
| US-20130251763-A1 | TRANSDERMAL COMPOSITIONS | MICRODERMIS CORPORATION (US) | 2013-09-26 | — | — | US | disclosed |
| US-8536228-B2 | Transdermal compositions | MICRODERMIS CORPORATION (US) | 2013-09-17 | — | — | US | disclosed |
| US-20120022165-A1 | TRANSDERMAL COMPOSITIONS | MICRODERMIS CORPORATION (US) | 2012-01-26 | — | — | US | disclosed |
| US-8101163-B2 | Transdermal compositions | MICRODERMIS CORPORATION (US) | 2012-01-24 | — | — | US | disclosed |
| US-7893285-B2 | Transdermal compositions | MICRODERMIS CORPORATION (US) | 2011-02-22 | — | — | US | disclosed |
| US-7888393-B2 | Transdermal compositions | MICRODERMIS CORPORATION (US) | 2011-02-15 | — | — | US | disclosed |
| US-20100227929-A1 | TRANSDERMAL COMPOSITIONS | DRS. SOLUTIONS, LLC (US) | 2010-09-09 | — | — | US | disclosed |
| US-20100203005-A1 | TRANSDERMAL COMPOSITIONS | DRS. SOLUTIONS, LLC (US) | 2010-08-12 | — | — | US | disclosed |
| US-20100197795-A1 | TRANSDERMAL COMPOSITIONS | DRS. SOLUTIONS, LLC (US) | 2010-08-05 | — | — | US | disclosed |
| US-20040122105-A1 | Transdermal compositions | DRSS GLOBAL, LLC | 2004-06-24 | — | — | US | disclosed |
| WO-2004026259-A2 | TRANSDERMAL COMPOSITIONS | BETTLE GRISCOM III (US) | 2004-04-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130251763-A1 | TRANSDERMAL COMPOSITIONS | S100A10, TMSB10, FFAR3 | USP2 4442/4885MEN1 2596/4885KMT2A 4309/4885 |
| US-20100203005-A1 | TRANSDERMAL COMPOSITIONS | S100A10, TMSB10, FFAR3 | USP2 4442/4885MEN1 2596/4885KMT2A 4309/4885 |
| US-20100197795-A1 | TRANSDERMAL COMPOSITIONS | S100A10, TMSB10, DGKG | USP2 4333/4885MEN1 2399/4885KMT2A 4294/4885 |
| US-20120022165-A1 | TRANSDERMAL COMPOSITIONS | S100A10, TMSB10, FFAR3 | USP2 4442/4885MEN1 2596/4885KMT2A 4309/4885 |
| US-20100227929-A1 | TRANSDERMAL COMPOSITIONS | S100A10, TMSB10, FFAR3 | USP2 4442/4885MEN1 2596/4885KMT2A 4309/4885 |
| US-20040122105-A1 | Transdermal compositions | S100A10, DGKG, COX6C | USP2 4264/4885MEN1 4028/4885KMT2A 4189/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.